Apyx Medical Corporation Common Stock APYX
Analyst Ratings
- Consensus
- Buy — 6 Buy · 0 Hold · 0 Sell (6 analysts)
- Avg. Price Target
- $6.50 (+121.1% upside)
Key Stats
- Today's Range
- $2.92 – $3.05
- 50-Day Range
- $2.25 – $3.30
- 52-Week Range
- $2.25 – $5.08
- Volume
- 72K shs
- Average Volume
- 176K shs
- Market Cap
- $123.84 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.26%
- Days to Cover
- 1.00
About Apyx Medical Corporation Common Stock
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Surgical Aesthetics and Original Equipment Manufacturing (OEM). Its Surgical Aesthetics segment derives the majority of its revenue.
Related Stocks
Compare head-to-head: APYX vs SYK·APYX vs BSX·APYX vs MDLN·APYX vs RMD
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.